TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential
Abstract Tumor development, involving both cell growth (mass accumulation) and cell proliferation, is a complex process governed by the interplay of multiple signaling pathways. TET2 mainly functions as a DNA dioxygenase, which modulates gene expression and biological functions via oxidation of 5mC...
Main Authors: | Jing He, Mingen Lin, Xinchao Zhang, Ruonan Zhang, Tongguan Tian, Yuefan Zhou, Wenjing Dong, Yajing Yang, Xue Sun, Yue Dai, Yue Xu, Zhenru Zhang, Ming Xu, Qun-Ying Lei, Yanping Xu, Lei Lv |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-08-01
|
Series: | Cell Discovery |
Online Access: | https://doi.org/10.1038/s41421-023-00567-7 |
Similar Items
-
Publisher Correction: TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential
by: Jing He, et al.
Published: (2023-09-01) -
mTORC1-Mediated Angiogenesis is Required for the Development of Rosacea
by: Qinqin Peng, et al.
Published: (2021-12-01) -
Defects in mTORC1 Network and mTORC1-STAT3 Pathway Crosstalk Contributes to Non-inflammatory Hepatocellular Carcinoma
by: Ting Li, et al.
Published: (2020-04-01) -
mTORC1 and mTORC2 Levels in Patients With Psoriasis
by: İlayda Esna Gülsunay, et al.
Published: (2024-10-01) -
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
by: Haiyang Tang, PhD, et al.
Published: (2018-12-01)